Member Info for RENE_to_40p

What a joke it is that buys and sells aren't just transparently reported in the first place. Why all the smoke and mirrors?

Maybe way back but in recent times it reached about £6.30 in 2015 and that was before any clear efficacy being shown and before an £80 million deal with a Chinese pharma. So yes, profoundly undervalued at half of that price now.

... only now they're buys

Virtually all trading seems to have dried up. I expect we'll now see it creep up in anticipation of the next RNS.

It's a perfectly normal trading pattern to be expected IMO. It's gone up massively, some people will be happy to cash in their winnings and in the absence of news it'll drift down a bit until some kind of threshold is met when there are more people anticipating the next RNS than there are profit takers and then it'll go up again. However the sustained movement will depend on the contents of the RNS's and with more game-changing possibilities on the horizon I for one am very happy to watch it play out in the expectation of MASSIVE gains when we hear about the next partnering deal, payment milestones from Fosun, continued efficacy in RP or something positive happening in the stroke or exosome platforms.

Enormous potential here and unless you want to cash in a profit, you need to be in it to win it.

Oh well, there's always next week :)

£4 by next Friday

Australia
Antarctica

This has got blue finish and massive leg up next week written all over it

As has been pointed out on here, the 2nd cohort in the RP trial have slightly *better* baseline vision than the first so presumably we have to manage our expectations and not expect as spectacular results as with the 1st. Personally I think it'll be a fantastic result if they experience any level of improvement. That would then help RENE determine the most suitable patients for commercial treatment in the future.

Any improvement would be fantastic not only for the patients concerned but it will validate that the impressive improvements in the 1st cohort was not just some kind of fluke. That's important with such a tiny sample size.

Apologies eggonaroll, I thought you'd cashed in and fled! I'm glad you're still around.

Looking really strong over the last couple of days, good times ahead.

... when you want him/her for some shameless ramping?

Gave it all the large then bottled it and sold out when it dropped 10p, no doubt.

LOL ... yes, a nice image that!

I suppose you've always got the potential leaking of information from the patients, their extended family and friends and the clinical practitioners overseeing the trials as well to consider. The point is the company should always release pertinent information (positive or negative) as soon as it becomes available to them.

The SP is only back to where it was "naturally" after the Fosun deal and later RNS confirming continued efficacy in the RP trial anyway so it's not exactly surging ahead with no news. It's just a recovery after a bit of selling IMO.

Of course a positive RNS would always be welcome nonetheless.

Well it's there for everyone to buy if you want in. The board have enough share options to make themselves very rich without needing to do any shady dealing anyhow.

The last couple of weeks seems to have successfully flushed out the doubters, short-term profit takers and weak holders, the sub-£3 brigade. Now we can power on from here.

£4 sooooooon :)

GLA

I thought (and still think) it will settle around the 275p mark but I'm pulling down the blinds now and going to preserve my sanity by not looking every 5 minutes and checking back in a couple of months.

Good luck folks! Keep the faith, keep your RENE and you'll twenty-bag from here :)

You beat me to it.

The company states: "The second cohort comprised three patients with a greater baseline level of visual acuity than those patients earlier in the study"

It's very clear they're going places and fast.

Expect exosome commercial deal very soon (that's IMO only) :)

Can't knock anyone taking a profit but for me this is such an exciting time for RENE I wouldn't dream of selling.

I want to see the results for the latest cohort of RP patients. If they've shown improvements I reckon were in business and in for 10-fold+ increases from here because it will dramatically increase the chances of the treatment getting to market.

Good luck all

http://www.reneuron.com/news/events/

ReNeuron is presenting at the following events.

Allogeneic Cell Therapies Summit
Start date: May 7, 2019
End date: May 9, 2019
Location: Boston, USA